These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31182375)

  • 1. Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency.
    Consuelo-Sánchez A; Vázquez-Frias R; Reyes-De La Rosa A; Acosta-Rodríguez-Bueno CP; Ortal-Vite MP; Cebolla JJ
    Ann Hepatol; 2019; 18(4):646-650. PubMed ID: 31182375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
    Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
    Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
    Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE
    World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
    Cappuccio G; Donti TR; Hubert L; Sun Q; Elsea SH
    J Inherit Metab Dis; 2019 May; 42(3):509-518. PubMed ID: 30684275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare cause of hepatomegaly and dyslipidemia: lysosomal acid lipase deficiency.
    Gürbüz BB; Güney İ; Bulut FD; Dilek O
    Turk J Pediatr; 2020; 62(5):831-835. PubMed ID: 33108087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.
    Scott SA; Liu B; Nazarenko I; Martis S; Kozlitina J; Yang Y; Ramirez C; Kasai Y; Hyatt T; Peter I; Desnick RJ
    Hepatology; 2013 Sep; 58(3):958-65. PubMed ID: 23424026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemia.
    Sjouke B; Defesche JC; de Randamie JSE; Wiegman A; Fouchier SW; Hovingh GK
    Atherosclerosis; 2016 Aug; 251():263-265. PubMed ID: 27423329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal acid lipase deficiency in pediatric patients: a scoping review.
    Witeck CDR; Schmitz AC; de Oliveira JMD; Porporatti AL; De Luca Canto G; Pires MMS
    J Pediatr (Rio J); 2022; 98(1):4-14. PubMed ID: 33964214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency.
    Del Angel G; Hutchinson AT; Jain NK; Forbes CD; Reynders J
    Hum Mutat; 2019 Nov; 40(11):2007-2020. PubMed ID: 31180157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
    Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
    Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
    Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
    J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.
    Anushiravani A; Jafari Khamirani H; Mohamadkhani A; Mani A; Dianatpour M; Malekzadeh R
    Arch Iran Med; 2023 Feb; 26(2):86-91. PubMed ID: 37543928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
    Pagani F; Pariyarath R; Garcia R; Stuani C; Burlina AB; Ruotolo G; Rabusin M; Baralle FE
    J Lipid Res; 1998 Jul; 39(7):1382-8. PubMed ID: 9684740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
    Porto AF
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
    Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cholesteryl ester storage disease among hypercholesterolemic subjects and functional characterization of mutations in the lysosomal acid lipase gene.
    Vinje T; Wierød L; Leren TP; Strøm TB
    Mol Genet Metab; 2018 Feb; 123(2):169-176. PubMed ID: 29196158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.